These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 9808609)

  • 1. Mechanism of action of fibrates on lipid and lipoprotein metabolism.
    Staels B; Dallongeville J; Auwerx J; Schoonjans K; Leitersdorf E; Fruchart JC
    Circulation; 1998 Nov; 98(19):2088-93. PubMed ID: 9808609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.
    Schoonjans K; Staels B; Auwerx J
    J Lipid Res; 1996 May; 37(5):907-25. PubMed ID: 8725145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
    Schoonjans K; Staels B; Auwerx J
    Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of lipid and lipoprotein metabolism by PPAR activators.
    Gervois P; Torra IP; Fruchart JC; Staels B
    Clin Chem Lab Med; 2000 Jan; 38(1):3-11. PubMed ID: 10774955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of actions of statins and fibrates].
    Duriez P
    Therapie; 2003; 58(1):5-14. PubMed ID: 12822195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs).
    Staels B; Schoonjans K; Fruchart JC; Auwerx J
    Biochimie; 1997; 79(2-3):95-9. PubMed ID: 9209702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
    Fruchart JC; Duriez P
    Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
    Fruchart JC; Duriez P; Staels B
    Curr Opin Lipidol; 1999 Jun; 10(3):245-57. PubMed ID: 10431661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates.
    Lefebvre AM; Peinado-Onsurbe J; Leitersdorf I; Briggs MR; Paterniti JR; Fruchart JC; Fievet C; Auwerx J; Staels B
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1756-64. PubMed ID: 9327774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates.
    Vu-Dac N; Chopin-Delannoy S; Gervois P; Bonnelye E; Martin G; Fruchart JC; Laudet V; Staels B
    J Biol Chem; 1998 Oct; 273(40):25713-20. PubMed ID: 9748239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
    Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
    J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of apo A-I gene expression by fibrates.
    Staels B; Auwerx J
    Atherosclerosis; 1998 Apr; 137 Suppl():S19-23. PubMed ID: 9694537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans.
    Shah A; Rader DJ; Millar JS
    Atherosclerosis; 2010 May; 210(1):35-40. PubMed ID: 20005515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.
    Auwerx J; Schoonjans K; Fruchart JC; Staels B
    J Atheroscler Thromb; 1996; 3(2):81-9. PubMed ID: 9226459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation.
    Andersson Y; Majd Z; Lefebvre AM; Martin G; Sechkin AV; Kosykh V; Fruchart JC; Najib J; Staels B
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):115-21. PubMed ID: 9888873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibric acids: effects on lipids and lipoprotein metabolism.
    Grundy SM; Vega GL
    Am J Med; 1987 Nov; 83(5B):9-20. PubMed ID: 3318457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanism of action of the fibrates].
    Fruchart JC; Duriez P; Staels B
    J Soc Biol; 1999; 193(1):67-75. PubMed ID: 10851558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of fibrates in postprandial lipemia.
    Kolovou GD; Kostakou PM; Anagnostopoulou KK; Cokkinos DV
    Am J Cardiovasc Drugs; 2008; 8(4):243-55. PubMed ID: 18690758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor.
    Bisgaier CL; Essenburg AD; Barnett BC; Auerbach BJ; Haubenwallner S; Leff T; White AD; Creger P; Pape ME; Rea TJ; Newton RS
    J Lipid Res; 1998 Jan; 39(1):17-30. PubMed ID: 9469582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.